Valproic Acid and Stevens-Johnson Syndrome: A Vital Warning for Patient Safety | Chapter 10 | Disease and Health Research: New Insights Vol. 10

 Stevens-Johnson Syndrome is a severe condition that affects the skin and mucous membranes, often caused by medications or infections. Early diagnosis and treatment are crucial for improving outcomes and preventing lasting damage. This case study details the experience of a three-year-old boy who developed SJS after beginning valproate treatment for seizure management following a traumatic brain injury. Initially, he showed fever, facial redness, and a runny nose, which progressed to a severe rash and blisters. The patient is a known case of traumatic brain injury fall from the fifth floor in September 2022— developed seizures after acquired brain injury fall. A dermatologist confirmed the diagnosis of SJS linked to valproate. Swift diagnosis, discontinuation of the offending drug, and supportive care are essential in managing SJS such as IV fluids, wound management, and preventing serious complications. Early intervention and comprehensive care from various medical professionals are crucial for improving patient outcomes. Further research and awareness are essential to understand better the risk factors and mechanisms underlying drug-induced SJS and to improve prevention and treatment strategies.

 

Author (s) Details

Jafrin Sadiq Abdul Razack
Thumbay University Hospital, Ajman, United Arab Emirates.

 

Syeda Juveria Hussaini
Thumbay University Hospital, Ajman, United Arab Emirates.

 

Saud Khaled Aldoseri
Bahrain Defense Force Hospital, Bahrain.

Hisham Abubacker Musthafa
Gulf Medical University, Ajman, United Arab Emirates.

Antony Calvin Ossanam
Gulf Medical University, Ajman, United Arab Emirates.

 

Ibtisam Akram
Gulf Medical University, Ajman, United Arab Emirates.

 

Sahil Asgar Ali
Prime Hospital, Dubai, United Arab Emirates.

Ajimal Sainul
Thumbay University Hospital, Ajman, United Arab Emirates.

 

Vivek Karan
Prime Hospital, Dubai, United Arab Emirates.

 

Please see the book here:- https://doi.org/10.9734/bpi/dhrni/v10/3208

Glial Cell-Targeted Treatments for Bipolar Disorder: A Systematic Review of Available Data and Clinical Perspectives | Chapter 6 | Novel Research Aspects in Medicine and Medical Science Vol. 2

 Bipolar disorder poses meaningful challenges to the mental health society, and effective situation strategies are crucial in directing this complex condition. This paper presents a comprehensive orderly review of treatment approaches for bipolar disorder, accompanying a specific devote effort to something synthesizing evidence from treatment directions and clinical trials. A orderly search was conducted utilizing Google Scholar, yielding 375 relevant documents, during the ending from June 1, 2022, to August 30, 2022.The primary objective of this study search out provide an revised and rigorous evaluation of the existent treatment guidelines and dispassionate trial evidence for bipolar disorder. By checking a wide range of interventions, this review aims to offer clinicians and investigators valuable insights into evidence-located practices for the management of this disorder.The verdicts of this review reveal essential situation modalities for manic-depressive illness. Lithium emerges as a critical pharmacological mediation for controlling and lessening severe mood adventures. Additionally, olanzapine demonstrates productiveness in managing acute crazy or mixed episodes of manic-depressive illness. Moreover, Cariprazine shows promise in achieving better influence or remission outcomes.  Lurasidone is emphasize for its potential in reconstructing cognitive performance between individuals accompanying bipolar disorder.Furthermore, this study underscores the significance of addressing co-morbid environments in bipolar disorder administration. For instance, quetiapine is identified as an effective situation for improving sleep condition and co-morbid anxiety. The consolidation of carbamazepine and lithium emerges as a favored approach in managing psychotic madness with co-morbidity. Adjunctive olanzapine or lamotrigine is urged for treating co-nasty anxiety, while mood stabilizers confirm beneficial in calling co-morbid bulimia. Moreover, fatigue situation considerations suggest the exercise of a dawn simulator.In agreements of dietary recommendations, the review stresses the significance of adopting a healthful diet. Probiotics intake and attention to the balance of oily acids are suggested to support overall prosperity in patients with manic-depressive illness.In conclusion, this systematic review provides inclusive insights into evidence-located treatment options for manic-depressive illness. By evaluating the influence of various interventions, it offers clinicians and scientists valuable guidelines to improve the management of bipolar disorder efficiently. The findings of this study focal point the critical function of treatment guidelines and dispassionate trials in numbering the knowledge base and improving effects for individuals endure bipolar disorder.

Author(s) Details:

Julia Wang,
Lumiere Academy, Shanghai, China.

Please see the link here: https://stm.bookpi.org/NRAMMS-V2/article/view/11802